Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab.
about
The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysisThrough translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients.GSTT1 deletion is related to polycyclic aromatic hydrocarbons-induced DNA damage and lymphoma progressionAssociation between tumor necrosis factor-α gene polymorphisms and diffuse large B-cell lymphoma in Chinese Han population: evidence from two center case-control study and a meta-analysis.Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma.Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls.Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.
P2860
Q26795818-B318935D-E7A8-42BB-B0C7-A950A5AA299DQ33701863-9F06D61F-5739-4DE9-A0D7-EC600242931DQ35107033-21E7F81E-542A-4378-986C-ECE0EBCE01BFQ36375294-8DD9385B-EBEE-429E-85C4-A7E741FA0673Q38403881-7F6E2075-F5C4-448A-B0AC-C5B38C802D63Q38482170-44CC7947-9A46-4F66-8C32-E5148842E4FCQ38516259-D196993E-B596-48A2-9470-3CF5F7F10543Q41867161-6A26B529-AB07-4D95-BB21-2B05D70A561EQ47844224-CA45D7C1-A84E-42DE-B348-A4DE6ECD2BEDQ51339500-3D4A3A17-0ACC-453C-9F46-FFF8958ED11A
P2860
Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Influence of polymorphisms in ...... mphoma treated with rituximab.
@en
Influence of polymorphisms in ...... mphoma treated with rituximab.
@nl
type
label
Influence of polymorphisms in ...... mphoma treated with rituximab.
@en
Influence of polymorphisms in ...... mphoma treated with rituximab.
@nl
prefLabel
Influence of polymorphisms in ...... mphoma treated with rituximab.
@en
Influence of polymorphisms in ...... mphoma treated with rituximab.
@nl
P2093
P2860
P50
P1433
P1476
Influence of polymorphisms in ...... mphoma treated with rituximab.
@en
P2093
Harald Holte
Olav E Yri
Per Olaf Ekstrøm
Vera Hilden
P2860
P304
P356
10.3109/10428194.2013.774392
P577
2013-04-02T00:00:00Z